Clipping of news on Brazilian Culture, Law and Citizenship
 


Health

Agency announces ban on drug

03/27/2012

This article was translated by an automatic translation system, and was therefore not reviewed by people.


 




The National Health Surveillance Agency (ANVISA) published on Monday (26/3) in the Official Gazette (DOU), the precautionary ban on the entire country, batch 1220/10 the drug Lithium Carbonate 300mg tablets, manufacture 10/2010 and validity 9/2012. The drug is manufactured by the company Hipolabor Pharmaceuticals Ltd. and has been closed by presenting unsatisfactory result in the dissolution test.

The precautionary ban applies for 90 days after its date of publication in the Official Gazette. During this time the product should not be forbidden used or marketed.

Gathering

The company Uci-Farma Pharmaceutical Industries Ltd. will make the voluntary payment of some batches of the product Propan 25mg tablets. The payment is necessary due to the proof of quality deviation in the bull. The product should not be sold or consumed.

The lots that will be collected are: batch 110466 - fabricação07/2011, expiration 07/2013, lot 110 467 - manufacture 07/2011, expiry 07/2013, lot 110 526 - manufacture 09/2011, expiry 09/2013, lot 110 640 - 10 manufacturing / 2011, expiry 10/2013, Lot 110741, - manufacture 11/2011, expiry 11/2013, lot 110 482 - manufacture 07/2011, expiry 07/2013 (free sample) and the batch 110527, manufacturing 09/2011, valid 09/2013 (free sample).

Will also be collected voluntarily by Ranbaxy Pharmaceuticals ltd manufacturing lots 2235767-01/2011, expiry 12/2012, and lot 2227829 - manufacture 12/2010, expiry 11/2012, the product Imipenem cilastatin sodium 500 mg and 500 mg generic.
The product was collected by deviates quality and should not be sold.



Press / Anvisa

Source: ANVISA

Our news are taken in full of our partner sites. For this reason, we can not change the content of these up in case of typing errors.

This article was translated by an automatic translation system, and was therefore not reviewed by people.

Important:
The JurisWay site does not interfere in the work provided by doctrine, why only reflect the opinions, ideas and concepts of their authors.


  Subjects list
 
  Copyright (c) 2006-2009. JurisWay - All rights reserved.